White Lighthouse Investment Management’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.57M Buy
9,275
+4
+0% +$684 0.22% 60
2025
Q4
$1.56M Sell
9,271
-1,022
-10% -$166K 0.22% 62
2025
Q3
$1.49M Sell
10,293
-1,070
-9% -$146K 0.23% 59
2025
Q2
$1.44M Buy
11,363
+32
+0.3% +$3.93K 0.23% 59
2025
Q1
$1.45M Sell
11,331
-808
-7% -$110K 0.26% 55
2024
Q4
$1.6M Sell
12,139
-380
-3% -$53.4K 0.28% 53
2024
Q3
$1.82M Sell
12,519
-49
-0.4% -$7.09K 0.33% 46
2024
Q2
$1.73M Sell
12,568
-9
-0.1% -$1.2K 0.33% 45
2024
Q1
$1.73M Sell
12,577
-185
-1% -$25.3K 0.35% 45
2023
Q4
$1.73M Buy
12,762
+350
+3% +$42.7K 0.38% 44
2023
Q3
$1.52M Sell
12,412
-50
-0.4% -$6.36K 0.37% 45
2023
Q2
$1.58M Buy
12,462
+60
+0.5% +$7.79K 0.38% 45
2023
Q1
$1.6M Buy
12,402
+78
+0.6% +$10.2K 0.4% 42
2022
Q4
$1.62M Hold
12,324
0.44% 42
2022
Q3
$1.44M Buy
12,324
+23
+0.2% +$2.86K 0.42% 44
2022
Q2
$1.45M Buy
12,301
+3
+0% +$356 0.41% 44
2022
Q1
$1.6M Sell
12,298
-197
-2% -$25.7K 0.41% 45
2021
Q4
$1.91M Sell
12,495
-159
-1% -$24.6K 0.48% 43
2021
Q3
$2.05M Sell
12,654
-197
-2% -$33.2K 0.55% 39
2021
Q2
$2.1M Buy
12,851
+206
+2% +$31.7K 0.58% 39
2021
Q1
$1.9M Buy
12,645
+150
+1% +$23.8K 0.58% 38
2020
Q4
$1.89M Sell
12,495
-355
-3% -$50.7K 0.6% 37
2020
Q3
$1.74M Sell
12,850
-1,351
-10% -$183K 0.6% 36
2020
Q2
$1.94M Buy
14,201
+27
+0.2% +$3.44K 0.71% 36
2020
Q1
$1.53M Buy
14,174
+50
+0.4% +$5.76K 0.64% 38
2019
Q4
$1.7M Buy
14,124
+466
+3% +$52K 0.62% 39
2019
Q3
$1.36M Sell
13,658
-200
-1% -$20.9K 0.55% 42
2019
Q2
$1.51M Sell
13,858
-200
-1% -$21.3K 0.63% 39
2019
Q1
$1.57M Buy
14,058
+2,030
+17% +$223K 0.72% 36
2018
Q4
$1.16M Buy
12,028
+75
+0.6% +$7.96K 0.64% 41
2018
Q3
$1.46M Sell
11,953
-1,105
-8% -$130K 0.74% 33
2018
Q2
$1.43M Buy
13,058
+195
+2% +$20.9K 0.79% 29
2018
Q1
$1.37M Sell
12,863
-410
-3% -$45.4K 0.79% 30
2017
Q4
$1.42M Buy
+13,273
New +$1.42M 0.81% 31

Other funds holding IBB

White Lighthouse Investment Management's IBB Position: Q1 2026 in Review

White Lighthouse Investment Management increased its iShares Biotechnology ETF (IBB) stake by 0.04% in Q1 2026, buying an estimated $684 and bringing the position to 9,275 shares worth $1.57M. The position accounts for 0.22% of the portfolio, ranked #60.

White Lighthouse Investment Management first reported a position in IBB in Q4 2017 and has held it in 34 quarters since. The position peaked at $2.1M in Q2 2021. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • White Lighthouse Investment Management held 9,275 shares of iShares Biotechnology ETF worth $1.57M as of Q1 2026.
  • White Lighthouse Investment Management bought 4 iShares Biotechnology ETF shares in Q1 2026, an estimated $684.
  • iShares Biotechnology ETF made up 0.22% of White Lighthouse Investment Management's portfolio in Q1 2026, its #60 holding.
  • White Lighthouse Investment Management first reported a position in iShares Biotechnology ETF in Q4 2017 and has held it in 34 quarters since.
  • White Lighthouse Investment Management's iShares Biotechnology ETF position peaked at $2.1M in Q2 2021.
  • 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on White Lighthouse Investment Management's 13F filing for Q1 2026, filed 15 May 2026.